Matsumura, Itaru
Kindai University
4 papers on CoChatORCID 0000-0003-2818-4270
Most cited papers
- Verified
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations
Mizuki, M., Schwäble, J., Steur, C., Choudhary, C., Agrawal, S., Sargin, B., Steffen, B., Matsumura, I., Kanakura, Y., Böhmer, F. D., et al. (2003) · Blood
Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes
Cited by 298
- Verified
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
Usmani, S. Z., Schjesvold, F., Oriol, A., Karlin, L., Cavo, M., Rifkin, R. M., Yimer, H. A., LeBlanc, R., Takezako, N., McCroskey, R. D., et al. (2019) · The Lancet Haematology
Multiple Myeloma Research and TreatmentsBone health and treatments
Cited by 251
- Verified
Biologic significance of GATA-1 activities in Ras-mediated megakaryocytic differentiation of hematopoietic cell lines
Matsumura, I., Kawasaki, A., Tanaka, H., Sonoyama, J., Ezoe, S., Minegishi, N., Nakajima, K., Yamamoto, M., & Kanakura, Y. (2000) · Blood
Platelet Disorders and TreatmentsGenomics and Chromatin Dynamics
Cited by 53
- Verified
Nilotinib vs dasatinib in achieving MR4.5 for de novo chronic myeloid leukemia: the randomized JALSG CML212 study
Matsumura, I., Ohtake, S., Atsuta, Y., Kurata, M., Minami, Y., Takahashi, N., Nakaseko, C., Iriyama, N., Fujimaki, K., Kakihana, K., et al. (2024) · Blood Advances
Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research
Cited by 21
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free